Investing.com --Mizuho said it remains bullish on U.S. small- and mid-cap biotechnology heading into 2026, with flagging three stocks as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE